Pharmaceutical Investing Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
Pharmaceutical Investing Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
Medical Device Investing Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference
AMENDED FROM SOURCE - Blue Sky Uranium Increases and Closes 2nd and Final Tranche of the Oversubscribed Non-Brokered Private Placement
